THE FACT ABOUT YODA 1 THAT NO ONE IS SUGGESTING

Greater activation of critical oncogenic signalling pathways (PI3K/AKT, RAS/MAPK and MYC) upstream of ribosome biogenesis constitutes yet another hallmark of HGSC,nine and we hypothesise that inhibiting ribosome biogenesis can offer a highly effective cancer therapeutic selection.ten Certainly, we have proven encouraging responses with the ribosoma